Dr. James S. O'brien

Joseph Ferrucci, MD, specializes in diagnostic radiology and is board-certified by the American Board of Radiology. He practices at Quantum Imaging & Therapeutic Associates and is affiliated with UPMC Carlisle, UPMC Lititz, UPMC Hanover, UPMC West Shore, UPMC Community Osteopathic, and UPMC Harrisburg. Dr. Ferrucci received his medical degree from Boston University Chobanian & Avedisian School of Medicine and completed his residency program at The Johns Hopkins University School of Medicine, followed by his fellowship program at Massachusetts General Hospital - Harvard Medical School. Dr. Ferrucci is rated as a Distinguished provider by MediFind in the treatment of Progressive Familial Intrahepatic Cholestasis Type 2. His top areas of expertise are Tenosynovitis, Visceromegaly, Diverticular Disease, and Progressive Familial Intrahepatic Cholestasis Type 3.

Jay Goodman is a Radiologist in Lewisberry, Pennsylvania. Dr. Goodman is rated as a Distinguished provider by MediFind in the treatment of Progressive Familial Intrahepatic Cholestasis Type 2. His top areas of expertise are Ascites, Progressive Familial Intrahepatic Cholestasis Type 2, Progressive Familial Intrahepatic Cholestasis Type 1, Liver Embolization, and Bone Marrow Aspiration.

Maximilian Cho, MD, specializes in diagnostic radiology and is board-certified by the American Board of Radiology. He practices at Quantum Imaging & Therapeutic Associates and is affiliated with UPMC Memorial, UPMC Lititz, UPMC Hanover, UPMC Carlisle, UPMC West Shore, UPMC Community Osteopathic, and UPMC Harrisburg. Dr. Cho received his medical degree from the University of California, Irvine, School of Medicine and completed his residency program at Santa Barbara Cottage Hospital, followed by a fellowship program at the University of Southern California Keck Medical Center. Dr. Cho is rated as an Advanced provider by MediFind in the treatment of Progressive Familial Intrahepatic Cholestasis Type 2. His top areas of expertise are Visceromegaly, Non-Alcoholic Fatty Liver Disease, Bronchogenic Cyst, and Gallbladder Disease.